Published in J Infect on March 01, 1999
Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev (2007) 3.62
Severe Sepsis Associated with Lemierre's Syndrome: A Rare but Life-Threatening Disease. Case Rep Crit Care (2016) 0.83
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet (1999) 4.68
Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 4.02
Respiratory stroke volume variation assessed by oesophageal Doppler monitoring predicts fluid responsiveness during laparoscopy. Br J Anaesth (2013) 2.07
Predictability of the respiratory variation of stroke volume varies according to the definition of fluid responsiveness. Br J Anaesth (2014) 2.00
Brucellosis from sniffing bacteriological cultures. Lancet (1997) 1.70
Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients. Antimicrob Agents Chemother (1989) 1.62
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr (2001) 1.51
Gradient plate method to induce Streptococcus pyogenes resistance. J Antimicrob Chemother (1999) 1.50
Pandemic A(H1N1)2009 influenza virus detection by real time RT-PCR: is viral quantification useful? Clin Microbiol Infect (2010) 1.46
[Prognosis of acute tuberculous respiratory distress syndrome. 4 cases]. Presse Med (1995) 1.39
[Aspergillus fumigatus muscle abscess revealing invasive aspergillosis in a patient with AIDS]. Presse Med (1998) 1.38
Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother (1990) 1.35
A large French prospective cohort of HIV-infected patients: the Nadis Cohort. HIV Med (2009) 1.29
Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. Antivir Ther (2000) 1.24
Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer (1999) 1.20
Application of DNA amplification to pneumocystosis: presence of serum Pneumocystis carinii DNA during human and experimentally induced Pneumocystis carinii pneumonia. J Exp Med (1992) 1.17
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). J Infect Dis (1999) 1.12
In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. J Antimicrob Chemother (2005) 1.10
Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis (1999) 1.08
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection? HIV Med (2005) 1.07
Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health (2002) 1.07
A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol (1991) 1.06
Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrob Agents Chemother (1993) 1.05
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial. HIV Med (2009) 1.05
Overexpression of Fas/CD95 and Fas-induced apoptosis in a patient with idiopathic CD4+ T lymphocytopenia. Clin Infect Dis (1999) 1.04
Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review. Arch Dermatol (1998) 1.04
Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis (2002) 1.03
Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol (1997) 1.03
Inactivity of terbinafine in a rat model of pulmonary aspergillosis. Eur J Clin Microbiol Infect Dis (1990) 1.03
Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. Drugs Exp Clin Res (1992) 1.00
Allopurinol for treatment of visceral leishmaniasis in patients with AIDS. J Infect Dis (1989) 0.98
Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis (1997) 0.98
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial. AIDS Care (2010) 0.97
Antibiotic misuse: a prospective clinical audit in a French university hospital. Eur J Clin Microbiol Infect Dis (2007) 0.97
Phase separation induced by melittin in negatively-charged phospholipid bilayers as detected by fluorescence polarization and differential scanning calorimetry. Biochim Biophys Acta (1982) 0.97
Detection of Pneumocystis carinii in serum of AIDS patients with Pneumocystis pneumonia by the polymerase chain reaction. J Protozool (1992) 0.96
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group. Ann Intern Med (1997) 0.96
Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort). J Med Virol (1994) 0.96
HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice. Acta Clin Belg (2002) 0.95
Hepatobiliary scintigraphy in infancy. J Nucl Med (1998) 0.95
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen. HIV Med (2006) 0.94
Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. Clin Exp Immunol (1999) 0.93
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group. Drug Alcohol Depend (2000) 0.92
[Survey on the results of routine treatment of 1,199 pulmonary tuberculosis patients treated for the 1st time]. Bull Int Union Tuberc (1970) 0.92
Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. J Pharm Sci (1989) 0.92
The musculoskeletal complications of cystic fibrosis. J Paediatr Child Health (1998) 0.92
Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis (2008) 0.91
Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. Cell Death Dis (2011) 0.91
Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus-the 'D-shuttle' project. J Radiol Prot (2015) 0.91
Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen. J Infect (2002) 0.90
The diffusion of pefloxacin into bone and the treatment of osteomyelitis. J Antimicrob Chemother (1986) 0.90
Acute traumatic aortic rupture: early stent-graft repair. Eur J Cardiothorac Surg (2002) 0.90
Structure-function relationships for cardiotoxins interacting with phospholipids. Toxicon (1982) 0.90
Extracerebral toxoplasmosis in the acquired immunodeficiency syndrome (AIDS). Pathol Res Pract (1993) 0.90
Aerosol pentamidine. Ann Intern Med (1988) 0.89
Differences in HIV testing, knowledge and attitudes in pregnant women who deliver and those who terminate: Prevagest 1992--France. AIDS Care (1995) 0.88
Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs. Int J STD AIDS (2001) 0.88
Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus. J Infect Dis (1989) 0.87
In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae. J Antimicrob Chemother (1995) 0.87
Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir. HIV Clin Trials (2002) 0.87
[Senegal and malaria. True prophylactic failure of mefloquine]. Presse Med (2002) 0.87
[Effects of rifampicin on the pharmacokinetics of doxycycline]. Pathol Biol (Paris) (1987) 0.87
[Bacterial resistance and antibiotic prescriptions: perceptions, attitudes and knowledge of a sample of French GPs]. Med Mal Infect (2010) 0.87
Ability of stroke volume variation measured by oesophageal Doppler monitoring to predict fluid responsiveness during surgery. Br J Anaesth (2012) 0.86
[Hospital medical students: a population at risk for accidental exposure to blood]. Presse Med (1998) 0.86
Intestinal and extraintestinal Isospora belli infection in an AIDS patient. A second case report. Pathol Res Pract (1994) 0.86
Systemic infection with Trichosporon cutaneum in a patient with acute leukemia: report of a case. Cancer (1981) 0.86
[Discriminant factors of the risk of infection in routine digestive surgery. Trial apropos of 308 cases]. Ann Chir (1982) 0.86
Factors related to the prescription of antibiotics for young children with viral pharyngitis by general practitioners and paediatricians in southeastern France. Eur J Clin Microbiol Infect Dis (1999) 0.86
Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome. Arch Dermatol (1999) 0.85
[Motives for the prescription of antibiotics in the emergency department of the University Hospital Center in Nice. A prospective study]. Presse Med (2002) 0.85
[Adherence properties and production of slime by staphylococci: relation to pathogenicity]. Pathol Biol (Paris) (1990) 0.85
Variability of cutaneous lymphatic flow rates in melanoma patients. Melanoma Res (1998) 0.85
Skin manifestations of West Nile virus infection. Dermatology (2005) 0.84
Outbreak of typhoid fever on the French Riviera. Eur J Clin Microbiol Infect Dis (2000) 0.84
Growth monitoring: the role of community health volunteers. Public Health (1995) 0.84
[A case of external ophthalmomyiasis by Oestrus ovis, Linné, 1758 caught on the Nice beach (author's transl)]. Acta Trop (1981) 0.84
Six weeks antibiotic therapy for all bone infections: results of a cohort study. Eur J Clin Microbiol Infect Dis (2009) 0.83
[Secondary infection of joint implants: diagnostic criteria, treatment and prevention]. Rev Chir Orthop Reparatrice Appar Mot (2002) 0.83
Atypical leishmaniasis in a patient infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.83
Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients. HIV Med (2004) 0.83
Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patient. Scand J Infect Dis (2002) 0.83
Indications and impact of postoperative transesophageal echocardiography in cardiac surgical patients. Crit Care Med (2001) 0.83